Testing effectiveness (Phase 2)Study completedNCT00161772
What this trial is testing
Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.
Who this might be right for
Tick-borne Encephalitis
Pfizer